Inside U.S. Trade reports that USTR intends to table a full intellectual property chapter for the TPP by mid June, and that the pharmaceutical industry has been lobbying to reverse the policy deal struck by the Bush Administration and Congressional Democrats on May 10, 2007. The leaked intellectual property text that has circulated leaves out the controversial provisions covered by the agreement: data exclusivity, patent extensions, and linkage between patent offices and health regulators. The pharmaceutical industry wants USTR to use the Korea-US FTA language as a template for these provisions in the TPP, while health advocates want the May 10, 2007 Agreement to serve as a starting point for increasing countries’ flexibility in accessing generic medicines.
QUT Media4th November 2025 The United Kingdom Parliament is considering a bill aimed at making smoking obsolete, which has been
Speaking at the Global Expert Network on Copyright User Rights Symposium on 16 June 2025, Professor Christophe Geiger argues for
On 25 September 2025, Professor Wend Wendland, delivered the 14th Peter Jaszi Distinguished Lecture at American University in Washington D.C..
On September 18, 2025, the Italian Senate definitively approved the country’s first comprehensive framework law on artificial intelligence (AI). The
Por Andrés Izquierdo Durante la segunda semana de agosto, fui invitado a hablar en la Feria Internacional del Libro de
By Andrés Izquierdo AI, Copyright, and the Future of Creativity: Notes from the Panama International Book FairDuring the second week